Abstract:Hantavirus nucleocapsid protein (NP) inhibits protein kinase R (PKR) dimerization by an unknown mechanism to counteract its antiviral responses during virus infection. Here we demonstrate that NP exploits an endogenous PKR inhibitor P58 IPK to inhibit PKR. The activity of P58 IPK is normally restricted in cells by the formation of an inactive complex with its negative regulator Hsp40. On the other hand, PKR remains associated with the 40S ribosomal subunit, a unique strategic location that facilitates its free access to the downstream target eIF2α. Although both NP and Hsp40 bind to P58 IPK , the binding affinity of NP is much stronger compared to Hsp40. P58 IPK harbors an NP binding site, spanning to N-terminal TPR subdomains I and II. The Hsp40 binding site on P58 IPK was mapped to the TPR subdomain II. The high affinity binding of NP to P58 IPK and the overlap between NP and Hsp40 binding sites releases the P58 IPK from its negative regulator by competitive inhibition. The NP-P58 IPK complex is selectively recruited to the 40S ribosomal subunit by direct interaction between NP and the ribosomal protein S19 (RPS19), a structural component of the 40S ribosomal subunit. NP has distinct binding sites for P58 IPK and RPS19, enabling it to serve as bridge between P58 IPK and the 40S ribosomal subunit. NP mutants deficient in binding to either P58 IPK or RPS19 fail to inhibit PKR, demonstrating that selective engagement of P58 IPK to the 40S ribosomal subunit is required for PKR inhibition. Cells deficient in P58 IPK mount a rapid PKR antiviral response and establish an antiviral state, observed by global translational shutdown and rapid decline in viral load. These studies reveal a novel viral strategy in which NP releases P58 IPK from its negative regulator and selectively engages it on the 40S ribosomal subunit to promptly combat the PKR antiviral responses.

Selection of Peptide Inhibitors for Double-Stranded RNA-dependent Protein Kinase PKR

Double-Stranded Rna-Dependent Protein Kinase-Dependent Apoptosis Induction By A Novel Small Compound

Protein Kinase Inhibitor Peptide As a Tool to Specifically Inhibit Protein Kinase A

Study on Selectivity of Inhibitor BD2 for PKA over PKC beta II

Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays

The search for a PKR code—differential regulation of protein kinase R activity by diverse RNA and protein regulators

Antisense Candidates Against Protein Kinase C-alpha Designed Based on Phylogenesis and Simulant Structure of Mrna.

Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails.

[Cloning and Expression of PKR Gene and Affinity Purification of PKR Interacting Proteins].

Activation of PKR by a short-hairpin RNA

Structural and energetic insights into the selective inhibition of PKMYT1 against WEE1

Discovery of potential inhibitors targeting the kinase domain of polynucleotide kinase/phosphatase (PNKP): Homology modeling, virtual screening based on multiple conformations, and molecular dynamics simulation

An Isoform-Selective, Small-Molecule Inhibitor Targets the Autoregulatory Mechanism of p21-Activated Kinase

Hantaviruses use the endogenous host factor P58IPK to combat the PKR antiviral response

Protein Kinase R (PKR) as a Novel dsRNA Sensor in Antiviral Innate Immunity

Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.

Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation.

RNA circles with minimized immunogenicity as potent PKR inhibitors

Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells

Insights into Mechanism of Pyrido[2,3-D]pyrimidines As DYRK1A Inhibitors Based on Molecular Dynamic Simulations.